Orange Book product · Generic (ANDA)
ROCURONIUM BROMIDE
ROCURONIUM BROMIDE
At a glance
Nov 26, 2008
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 26, 2008
17 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
ROCURONIUM BROMIDE
Strength
50MG/5ML (10MG/ML)
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 078519
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ROCURONIUM BROMIDE
- 2025ROCURONIUM BROMIDEBrand (NDA)
NDA 219108 · B BRAUN MEDICAL
- 2025ROCURONIUM BROMIDEBrand (NDA)
NDA 217472 · FRESENIUS KABI USA
- 1994ZEMURONBrand (NDA)
NDA 020214 · ORGANON USA INC
- 2026ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 220124 · ASPIRO
- 2026ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 213476 · KNACK
- 2025ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 219674 · MANKIND PHARMA
- 2024ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 217092 · STERISCIENCE
- 2024ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 204918 · RISING
- 2024ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 215684 · SHANDONG
- 2023ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 217034 · HIKMA
- 2023ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 213453 · MEITHEAL
- 2023ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 216234 · CAPLIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
